Comparison of the anti-tumor effects of various whole-body hyperthermia protocols: Correlation with HSP 70 expression and composition of splenic lymphocytes

Immunological Investigations

Volumn 34, Issue 3, 2005, Pages 245-258

  Zhang, Honghai ^a   Wang, Weirong ^a   Zhang, Shuhong ^a   Huang, Weida ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

B16 melanoma model; HSP70; Lymphocytes; Thermal dose; WBH

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HEAT SHOCK PROTEIN 70;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CONTROL; CANCER INHIBITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERTHERMIC THERAPY; MALE; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN LYMPHOCYTE; T LYMPHOCYTE; WHOLE BODY HYPERTHERMIA;

ANIMALS; CELL LINE, TUMOR; HSP70 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; LYMPHOCYTE SUBSETS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; SPLEEN;

EID: 23844501272     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1081/IMM-200064460     Document Type: Article

References (43)

1. Atanackovic, D., Nierhaus, A., Neumeier, M., Hossfeld, D. K., Hegewisch-Becker, S. (2002). 41.8 whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol. Immunother. 51(11-12):603-613.
2. Binder, R. J., Blachere, N. E., Srivastava, P. K. (2001). Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules. J. Biol. Chem. 276(20):17163-17171.
3. Black, A. R., Subjeck, J. R. (1991). The biology and physiology of the heat shock and glucose-regulated stress protein systems. Methods Achiev. Exp. Pathol. 15:126-166.
4. Burd, R., Dziedzic, T. S., Xu, Y., Caligiuri, M. A., Subjeck, J. R., Repasky, E. A. (1998). Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J. Cell. Physiol. 177(1):137-147.
5. Castellino, F., Boucher, P. E., Eichelberg, K., Mayhew, M., Rothman, J. E., Houghton, A. N., Germain, R. N. (2000). Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J. Exp. Med. 191(11):1957-1964.
6. Chandawarkar, R. Y., Wagh, M. S., Srivastava, P. K. (1999). The dual nature of specific immunological activity of tumor-derived gp96 preparations. J. Exp. Med. 189:1437-1442.
7. Chen, X., Tao, Q., Yu, H., Zhang, L., Cao, X. (2002). Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunity. Immunol. Lett. 84(2):81-87.
8. Di, Y. P., Repasky, E. A., Subjeck, J. R. (1997). Distribution of HSP70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. J. Cell. Physiol. 172(1):44-54.
9. Evans, S. S., Wang, W. C., Bain, M. D., Burd, R., Ostberg, J. R., Repasky, E. A. (2001). Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood 97(9):2727-2733.
10. Falk, M. H., Issels, R. D. (2001). Hyperthermia in oncology. Int. J. Hypertherm. 17(1):1-18.
11. Hightower, L. E. (1991). Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 66(2):191-197.
12. Hildebrandt, B., Wust, P., Ahlers, O., Dieing, A., Sreenivasa, G., Kerne, T., Felix, R., Riess, H. (2002). The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol./Hematol. 43(1):33-56.
13. Hsu, K. F., Hung, C. F., Cheng, W. F., He, L., Slater, L. A., Ling, M., Wu, T. C. (2001). Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther. 8(5):376-383.
14. Ishii, T., Udono, H., Yamano, T., Ohta, H., Uenaka, A., Ono, T., Hizuta, A., Tanaka, N., Srivastava, P. K., Nakayama, E. (1999). Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J. Immunol. 162(3):1303-1309.
15. Kiang, J. G., Tsokos, G. C. (1998). Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol. Ther. 80(2):183-201.
16. Knox, J. D., Mitchel, R. E., Brown, D. L. (1991). Effects of hyperthermia on microtubule organization and cytolytic activity of murine cytotoxic T lymphocytes. Exp. Cell Res. 194(2):275-283.
17. Kraybill, W. G., Olenki, T., Evans, S. S., Ostberg, J. R., O'Leary, K. A., Gibbs, J. F., Repasky, E. A. (2002). A phase I study of fever-range whole body hyperthermia (FR-WBH) inpatients with advanced solid tumours: correlation with mouse models. Int. J. Hypertherm. 18(3):253-266.
18. Leon, S. A., Asbell, S. O., Edelstein, G., Arastu, H. H., Daskal, L, Sheehan, S., Plunkett, D. M., Guttmann, G. G., Fackel, A. J., Leon, O. (1993). Effects of hyperthermia on bone. I. Heating rate patterns induced by microwave irradiation in bone and muscle phantoms. Int. J. Hypertherm. 9(1):69-75.
19. Li, D. J., Zhou, S. L., Qiu, S. L., Qiao, S. J. (1987). Thermodamage, thermosensitivity and thermotolerance on normal swine esophagus. Int. J. Hypertherem. 3(2):142-151.
20. Li, D. J., Qiu, S. L., Zhou, S. L., Liu, H. L. (1988). Acute heat injury to the normal swine rectum. Int. J. Hypertherem. 4(2):191-201.
21. MacDonald, H. R. (1977). Effect of hyperthermia on the functional activity of cytotoxic T-lymphocytes. J. Natl. Cancer Inst. 59(4):1263-1268.
22. Manjili, M. H., Wang, X. Y., Park, J., Facciponte, J. G., Repasky, E. A., Subjeck, J. R. (2002). Immunotherapy of cancer using heat shock proteins. Front. Biosci. 7:d43-d52.
23. Manjili, M. H., Wang, X. Y., Chen, X., Martin, T., Repasky, E. A., Henderson, R., Subjeck, J. R. (2003). HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. J. Immunol. 171(8):4054-4061.
24. Massa, C., Guiducci, C., Arioli, I., Parenza, M., Colombo, M. P., Melani, C. (2004). Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70. Cancer Res. 64(4):1502-1508.
25. Matsuda, H., Strebel, F. R., Kaneko, T., Danhauser, L. L., Jenkins, G. N., Toyota, N., Bull, J. M. (1997). Long duration-mild whole body hyperthermia of up to 12 hours in rats: feasibility, and efficacy on primary tumour and axillary lymph node metastases of a mammary adenocarcinoma: implications for adjuvant therapy. Int. J. Hypertherm. 13(1):89-98.
26. Oki, Y., Younes, A. (2004). Heat shock protein-based cancer vaccines. Expert Rev. Vaccines 3(4):403-411.
27. Ostberg, J. R., Repasky, E. A. (2000a). Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte populations. Int. J. Hypertherm. 16(1):29-43.
28. Ostberg, J. R., Repasky, E. A. (2000b). Use of mild, whole body hyperthermia in cancer therapy. Immunol. Invest. 29(2):139-142.
29. Ostberg, J. R., Patel, R., Repasky, E. A. (2000). Regulation of immune activity by mild (fever-range) whole body hyperthermia: effects on epidermal Langerhans cells. Cell Stress Chaperones 5(5):458-461.
30. Ostberg, J. R., Gellin, C., Patel, R., Repasky, E. A. (2001). Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response. J. Immunol. 167(5):2666-2670.
31. Ostberg, J. R., Kaplan, K. C., Repasky, E. A. (2002). Induction of stress proteins in a panel of mouse tissues by fever-range whole body hyperthermia. Int. J. Hypertherm. 18(6):552-562.
32. Overgaard, J., Gonzalez Gonzalez, D., Hulshof, M. C., Arcangeli, G., Dahl, O., Mella, O., Bentzen, S. M. (1995). Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 345(8949):540-543.
33. Overgaard, J., Gonzalez Gonzalez, D., Hulshof, M. C., Arcangeli, G., Dahl, O., Mella, O., Bentzen, S. M. (1996). Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int. J. Hypertherm. 12(1):3-20.
34. Prionas, S. D., Taylor, N. A., Fajardo, L. F., Kelly, N. I., Nelsen, T. S., Hahn, G. M. (1985). Thernosensitivity to single and double heat treatment and normal canine liver. Cancer Res. 45(10):4791-4797.
35. Robins, H. I., Rushing, D., Kutz, M., Tutsch, K. D., Tiggelaar, C. L., Paul, D., Spriggs, D., Kraemer, C., Gillis, W., Feierabend, C., Arzoomanian, R. Z., Longo, W., Alberti, D., d'Oleire, F., Qu, R. P., Wilding, G., Stewart, J. A. (1997). Phase I clinical trial of carboplatin and 41.8 whole body hyperthermia in cancer patients. J. Clin. Oncol. 15(1):158-164.
36. Sminia, P., van der Zee, J., Wondergem, G., Haveman, J. (1994). Effect of hyperthermia on the central nerves system: a review. Int. J. Hypertherm. 10(1):1-30.
37. Srivastava, P. (2002). Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev., Immunol. 2(3):185-194.
38. Suit, H. D., Shwayder, M. (1974). Hyperthermia: potential as an anti-tumor agent. Cancer 34(1):122-129.
39. Udono, H., Srivastava, P. K. (1994). Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol. 152(11):5398-5403.
40. Wagner, A. C., Weber, H., Jonas, L., Nizze, H., Strowski, M., Fiedler, F., Printz, H., Steffen, H., Goke, B. (1996). Hyperthermia induces heat shock protein expression and protection against cerulein-induced pancreatic in rats. Gastroenterology 111(5):1333-1342.
41. Wang, W. C., Goldman, L. M., Schleider, D. M., Appenheimer, M. M., Subjeck, J. R., Repasky, E. A., Evans, S. S. (1998). Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. J. Immunol. 160(2):961-969.
42. Wang, X. Y., Kazim, L., Repasky, E. A., Subjeck, J. R. (2001). Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J. Immunol. 165(1):490-497.
43. Welch, W. J. (1992). Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol. Rev. 72(4):1063-1081.